JME

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, W
Right arrow Articles by Carter, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, W
Right arrow Articles by Carter, L
J Med Ethics 2004;30:337-340
© 2004 BMJ Publishing Group Ltd & Institute of Medical Ethics


SYMPOSIUM ON DRUGS

Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence

W Hall, L Carter

Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia

Correspondence to:
Prof W Hall
Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia QLD, Australia 4072; w.hall{at}imb.uq.edu.au
ABSTRACT
A "cocaine vaccine" is a promising immunotherapeutic approach to treating cocaine dependence which induces the immune system to form antibodies that prevent cocaine from crossing the blood brain barrier to act on receptor sites in the brain. Studies in rats show that cocaine antibodies block cocaine from reaching the brain and prevent the reinstatement of cocaine self administration. A successful phase 1 trial of a human cocaine vaccine has been reported. The most promising application of a cocaine vaccine is to prevent relapse to dependence in abstinent users who voluntarily enter treatment. Any use of a vaccine to treat cocaine addicts under legal coercion raises major ethical issues. If this is done at all, it should be carefully trialled first, and only after considerable clinical experience has been obtained in using the vaccine to treat voluntary patients. There will need to be an informed community debate about what role, if any, a cocaine vaccine may have as a way of preventing cocaine addiction in children and adolescents.


Keywords: cocaine; vaccine; drug dependence; treatment; ethics; public policy




This article has been cited by other articles:


Home page
J. Med. EthicsHome page
R E Ashcroft
Drugs symposium: introduction
J. Med. Ethics, August 1, 2004; 30(4): 332 - 332.
[Full Text] [PDF]


Home page
J. Med. EthicsHome page
R E Ashcroft and C Franey
Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter
J. Med. Ethics, August 1, 2004; 30(4): 341 - 343.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd & Institute of Medical Ethics.